PND76 - THE ECONOMIC CONSEQUENCES OF BENEFITS OF DELAYED-RELEASE DIMETHYL FUMARATE TREATMENT VERSUS BETA INTERFERONS AND GLATIRAMER ACETATE ON ABILITY TO WORK OF MULTIPLE SCLEROSIS PATIENTS IN ITALY

Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.2042
https://www.valueinhealthjournal.com/article/S1098-3015(18)35344-0/fulltext
Title : PND76 - THE ECONOMIC CONSEQUENCES OF BENEFITS OF DELAYED-RELEASE DIMETHYL FUMARATE TREATMENT VERSUS BETA INTERFERONS AND GLATIRAMER ACETATE ON ABILITY TO WORK OF MULTIPLE SCLEROSIS PATIENTS IN ITALY
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35344-0&doi=10.1016/j.jval.2018.09.2042
First page :
Section Title :
Open access? : No
Section Order : 1398
Categories :
Tags :
Regions :
ViH Article Tags :